
|Podcasts|September 21, 2021
Dr. Allaway on the increased efficiency of transperineal biopsies
Author(s)Urology Times staff
“We need to do a better job sampling the prostate,” says Matthew J. Allaway, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Matthew J. Allaway, MD. He discusses how his new technology, The PrecisionPoint Transperineal Access System, is used for detecting prostate cancer in patients. Matthew J. Allaway, MD, is the founder and president of Perinealogic and a urologist and managing partner at Urology Associates, Cumberland, Maryland.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
3
Farah Rahman, MD, on monitoring resident wellness using biofeedback
4
John Sfakianos, MD, on dual immune checkpoint inhibition in NMIBC
5






